Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Eli Lilly sues medical spas and vendors for selling ... Lilly tirzepatide injection shortage was resolved. Also Read: Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance ...

FTC sues drug middlemen for ... Compounding pharmacies are calling for the FDA to reconsider its decision, as both Eli Lilly and Novo Nordisk attempt to crack down on unapproved versions of ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

If a consumer is harmed by a poor-quality product, it would be difficult to sue the seller ... pharmaceutical company Novo Nordisk came under intense pressure to offer patients without prescription ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs ... bows of insulin manufacturers like Eli Lilly, Novo Nordisk, and Sanofi, saying that the PBMs are ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

has initiated legal action to prevent compounding pharmacies from creating and distributing less expensive alternatives to its products. Novo Nordisk Sues to Block Cheaper Compounded Versions of ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly ... The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US – CVS Caremark, Express Scripts, and ...

Novo Nordisk – the company that makes Ozempic and Wegovy – has made clear it "does not directly or indirectly provide or sell bulk semaglutide to compounding pharmacies," and the FDA in ...